Table 4. Maximal cardiorespiratory test data for participants from the three groups at each evaluation (baseline: Evaluation 1; after 20 weeks: Evaluation 2; and after 40 weeks: Evaluation 3). Values are mean (Standard Error of Mean).
| Variables |
CFTFG |
HG |
CG |
| E1 |
E2 |
E3 |
E1 |
E2 |
E3 |
E1 |
E2 |
E3 |
| VO2 peak (L/min) |
1.82 (.20) |
2.21 (.21)* |
1.91 (.22) |
2.07 (.19) |
1.85 (.20) |
1.71 (.23) |
1.71 (.19) |
1.65 (.22) |
1.33 (.23) |
| VO2 peak (ml/kg/min) |
26.4 (2.7) |
28.7 (2.9) |
27.6 (3.0) |
28.1 (2.6) |
24.6 (2.7) |
23.8 (3.1) |
27.8 (2.5) |
26.8 (2.9) |
23.4 (3.1) |
| VCO2 (L/min) |
2.02 (.22) |
2.25 (.24) |
2.06 (.25) |
2.21 (.21) |
1.91 (.23) |
1.72 (.26)* |
1.80 (.21) |
1.62 (.25) |
1.44 (.26) |
| RER |
1.10 (.03) |
1.02 (.03)* |
1.07 (.03) |
1.07 (.03) |
1.03 (.03) |
1.01 (.04) |
1.04 (.03) |
.99 (.03) |
1.09 (.04)** |
| Peak HR (beat/min) |
150(7) |
157(7) |
160(8) |
153(7) |
149(7) |
143(9) |
155(6) |
145(8) |
147(9) |
| VEqO2 |
33.9 (1.6) |
30.3 (1.7)* |
35.3 (1.8)** |
33.1 (1.5) |
32.8 (1.6) |
30.4 (1.9) |
32.3 (1.5) |
31.5 (1.8) |
33.5 (1.9) |
| VEqCO2 |
31.0 (1.0) |
29.3 (1.2) |
32.1 (1.2) |
30.9 (1.0) |
31.4 (1.1) |
30.5 (1.3) |
31.1 (1.0) |
31.6 (1.2) |
30.0 (1.3) |
* Significant differences (p < 0.05) when compared to E1.** Significant differences (p < 0.05) between E2 vs E3.CFTFG (combined face-to-face group); HG (home-based group); CG (control group); E (evaluation); VO
2 peak (peak oxygen uptake); VCO
2 (carbon dioxide production); RER (respiratory exchange ratio); HR (heart rate); VEqO
2 (ventilatory equivalent for O
2); VEqCO
2 (ventilatory equivalent for CO
2).
